Exercise has been shown to be a powerful intervention for the treatment of many diseases that affect muscle function. The positive effects of exercise are largely considered to be the result of changes in both the number and functionality of mitochondria. The ways in which exercise mediates the changes in mitochondria are poorly understood. Members of the peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family of coactivators have been identified as being important to both normal muscle and mitochondria function. It is widely suggested that PGC-1? is responsible for most, if not all, of these changes in response to exercise. However, we observe that deletion of PGC-1? in skeletal muscle does not affect the adaptive changes in mitochondrial parameters. These data show that PGC-1? is not required for exercise-induced changes in mitochondria. In addition, the role that mitochondrial dynamics (fusion/fission) in improving muscle function in response to exercise is unknown and its contribution to removing bad and damaged mitochondria is unstudied. These observations reveal that our understanding of exercise-induced changes in skeletal muscle is incomplete. Therefore, the overall objective of this proposal is to understand how exercise and the PGC-1s affect mitochondria number and dynamics to improve muscle performance. Using genetic models, cellular imaging and mitochondrial assays we will attempt to address these very important questions. Results from this proposal have broad implications for our understanding of the benefits of exercise in the treatment of mitochondrial disorders.
The specific aims are to: 1) determine the contribution of PGC-1? and ? in regulating exercise-induced mitochondrial biogenesis;2) determine the role of exercise and PGC-1? and ? in regulating mitochondrial fusion and fission;3) test if fusion/fission is involved in the dramatic improvement conferred by exercise seen with advance aging. The candidate is completing his postdoctoral training in the Cardiovascular Institute (CVI) at Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School. His primary mentor is Dr. Zoltan Arany, Assistant Professor of Medicine, with extensive experience in PGC-1 coactivators, molecular biology and metabolism. His co-mentor is Dr. Laurie Goodyear, Associate Professor of Medicine, a world-renowned expert in exercise physiology and skeletal muscle. The candidate's long-term career goal is to establish an independent research program in exercise physiology and mitochondrial dynamics. To accomplish this goal, he has created a series of short-term goals designed to enhance his knowledge of mitochondrial function, skeletal muscle, exercise physiology and advanced imaging technology, which will be facilitated by his mentorship oversight team and a comprehensive career development plan. Results from this proposal will serve as the foundation and preliminary data for an R series proposal such as an R01 within 3-5 years.

Public Health Relevance

Exercise has been proven to be one of the best interventions in many disorders of the skeletal muscle system, such as diabetes and age-associated muscle wasting. However, the ways in which the beneficial effects of exercise are propagated within muscle are poorly understood. The purpose of this study is to determine how mitochondria are able to respond to exercise, thereby improving skeletal muscle performance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01AR062128-03
Application #
8721195
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Boyce, Amanda T
Project Start
2012-09-13
Project End
2017-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
$123,906
Indirect Cost
$8,956
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Rowe, Glenn C; Young, Martin E (2017) VEGF-B: friend or foe to the heart in times of nutrient excess? Am J Physiol Heart Circ Physiol 313:H244-H247
Loyd, Christine; Liu, Yanping; Kim, Teayoun et al. (2017) LDB1 Regulates Energy Homeostasis During Diet-Induced Obesity. Endocrinology 158:1289-1297
Rowe, Glenn C; Asimaki, Angeliki; Graham, Evan L et al. (2017) Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRR?. Am J Physiol Heart Circ Physiol 312:H662-H671
Chan, Mun Chun; Ziegler, Olivia; Liu, Laura et al. (2016) Heme oxygenase and carbon monoxide protect from muscle dystrophy. Skelet Muscle 6:41
Hinson, J Travis; Chopra, Anant; Lowe, Andre et al. (2016) Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis. Cell Rep 17:3292-3304
Ballmann, Christopher; Tang, Yawen; Bush, Zachary et al. (2016) Adult expression of PGC-1? and -1? in skeletal muscle is not required for endurance exercise-induced enhancement of exercise capacity. Am J Physiol Endocrinol Metab 311:E928-E938
Jang, Cholsoon; Oh, Sungwhan F; Wada, Shogo et al. (2016) A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med 22:421-6
Mendez, Sean; Watanabe, Louis; Hill, Rachel et al. (2016) The TreadWheel: A Novel Apparatus to Measure Genetic Variation in Response to Gently Induced Exercise for Drosophila. PLoS One 11:e0164706
Rowe, Glenn C; Safdar, Adeel; Arany, Zolt (2014) Running forward: new frontiers in endurance exercise biology. Circulation 129:798-810
Chan, Mun Chun; Rowe, Glenn C; Raghuram, Srilatha et al. (2014) Post-natal induction of PGC-1? protects against severe muscle dystrophy independently of utrophin. Skelet Muscle 4:2

Showing the most recent 10 out of 14 publications